Compare International Business Machines Corp (IBM) vs Manhattan Associates Inc (MANH) Price & Performance

IBM's stock trades at $210.5, down 1.02% over the past day, amid a bearish technical signal and recent volatility following a pre-announced Q2 2026 earnings miss. The company shows strong profitability with a net income margin of 15.61% and has beaten earnings estimates in three of the last four quarters. However, negative cash flow in 2025 and a 25% stock drop on July 14, 2026, due to lowered growth guidance have heightened investor concerns. Analyst consensus remains moderately positive with a $282.47 price target, but legal investigations into the guidance cut add uncertainty.

The outlook is cautious; solid fundamentals and a high dividend yield offer value, but execution risks and slowing revenue growth pose significant headwinds. Investment opportunity hinges on IBM's ability to stabilize performance and meet future earnings expectations, while key risks include ongoing legal scrutiny and competitive pressures in the technology sector.

Manhattan Associates (MANH) trades at $165.51, up 1.42% today, with strong technical momentum and bullish moving averages. The company shows robust profitability with a 19.68% net income margin and has beaten EPS estimates for three consecutive quarters. However, valuation ratios like a P/E of 46.37 suggest premium pricing. Recent news highlights an ongoing legal investigation into fiduciary duties by directors, while analyst consensus remains strongly positive with a $192.80 price target.

The outlook for MANH is cautiously optimistic, driven by consistent earnings beats and solid cash flow generation. Key opportunities include sustained cloud and AI adoption, but risks involve high valuation multiples, competitive pressures, and potential legal overhangs from the Rosen Law Firm investigation. Investors should weigh strong fundamentals against elevated price levels and external uncertainties.